Free Trial

Cardlytics (CDLX) News Today

Cardlytics logo
$3.59 -0.08 (-2.18%)
(As of 10:25 AM ET)
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Sees Significant Drop in Short Interest
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) saw a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 7,100,000 shares, a decrease of 6.7% from the October 15th total of 7,610,000 shares. Based on an average daily volume of 907,300 shares, the short-interest ratio is presently 7.8 days.
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Recommendation of "Hold" by Brokerages
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and on
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $86,154.74 in Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 25,118 shares of the company's stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $3.43, for a total value of $86,154.74. Following the transaction, the chief financial officer now directly owns 116,481 shares of the company's stock, valued at approximately $399,529.83. This represents a 17.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Cardlytics, Inc. stock logo
GSA Capital Partners LLP Has $1.22 Million Stake in Cardlytics, Inc. (NASDAQ:CDLX)
GSA Capital Partners LLP lifted its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 1,273.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 382,315 shares of the company's stock afte
Cardlytics, Inc. stock logo
Baillie Gifford & Co. Sells 261,874 Shares of Cardlytics, Inc. (NASDAQ:CDLX)
Baillie Gifford & Co. trimmed its holdings in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 31.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 567,396 shares of the company's stock after selling 261,874 shar
Cardlytics, Inc. stock logo
Cardlytics (NASDAQ:CDLX) Announces Earnings Results
Cardlytics (NASDAQ:CDLX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The business had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same quarter in the previous year, the firm posted ($0.26) earnings per share. Cardlytics's quarterly revenue was down 15.1% on a year-over-year basis.
Cardlytics, Inc. stock logo
Cardlytics (NASDAQ:CDLX) Stock Rating Upgraded by Craig Hallum
Craig Hallum upgraded Cardlytics from a "hold" rating to a "strong-buy" rating in a research report on Wednesday.
Cardlytics (CDLX) Gets a Hold from Lake Street
Cardlytics, Inc. stock logo
Cardlytics' (CDLX) "Hold" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a report on Thursday.
Cardlytics Reports Q3 2024 Financial Results
Cardlytics Shares Fall on Wider 3Q Loss
Cardlytics Announces Third Quarter 2024 Financial Results
Cardlytics Appoints Srishti Gupta to Board of Directors
Cardlytics (CDLX) Gets a Buy from Craig-Hallum
Cardlytics Q3 2024 Earnings Preview
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Short Interest Down 8.2% in October
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 7,610,000 shares, a drop of 8.2% from the September 30th total of 8,290,000 shares. Based on an average trading volume of 1,200,000 shares, the days-to-cover ratio is presently 6.3 days.
Cardlytics, Inc. stock logo
Cardlytics (CDLX) to Release Earnings on Wednesday
Cardlytics (NASDAQ:CDLX) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639563)
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Rating of "Reduce" by Brokerages
Shares of Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and six have given a hold recom
Cardlytics, Inc. stock logo
Cardlytics (NASDAQ:CDLX) Coverage Initiated at Evercore ISI
Evercore ISI began coverage on Cardlytics in a research report on Friday. They set an "in-line" rating and a $4.00 price objective for the company.
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP lowered its holdings in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 20.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 619,114 shares of the company's stock after sel
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells $18,282.88 in Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) insider Nicholas Hollmeyer Lynton sold 5,936 shares of the business's stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $3.08, for a total transaction of $18,282.88. Following the transaction, the insider now directly owns 85,445 shares of the company's stock, valued at approximately $263,170.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Cardlytics, Inc. stock logo
Renaissance Technologies LLC Buys 307,800 Shares of Cardlytics, Inc. (NASDAQ:CDLX)
Renaissance Technologies LLC raised its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 711.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 351,035 shares of the company's stock after acquiring an additional 307,800 sh
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Receives Average Recommendation of "Reduce" from Analysts
Shares of Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) have received an average recommendation of "Reduce" from the six analysts that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and five have assigned
Cardlytics, Inc. (CDLX): A Bull Case Theory
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Rating of "Reduce" by Analysts
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has earned a consensus recommendation of "Reduce" from the six analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation and five have issued a hold recommendation on the company.
Cardlytics, Inc. stock logo
Cardlytics, Inc. (NASDAQ:CDLX) Short Interest Update
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 8,620,000 shares, an increase of 14.6% from the July 31st total of 7,520,000 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is presently 7.3 days.
Get Cardlytics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.

My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)

One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...

The Next SpaceX Pre-IPO

CDLX Media Mentions By Week

CDLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDLX
News Sentiment

1.11

0.54

Average
Business Services
News Sentiment

CDLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDLX Articles
This Week

8

4

CDLX Articles
Average Week

Get Cardlytics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CDLX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners